Moonshot AI, the Beijing-based maker of the Kimi K3 model, confirmed Tuesday that it has closed a $3.5 billion financing round at a $35 billion post-money valuation, more than triple its $4.3 billion valuation from eight months ago, and far above the $1 billion to $2 billion it originally set out to raise, Bloomberg reported. The company is now approaching new investors about a follow-on round at a $50 billion pre-money valuation, targeting a final private raise before a Hong Kong initial public offering the company wants to complete as soon as this year.
The round’s arithmetic is straightforward: the $31.5 billion pre-money valuation that opened the round earlier in summer 2026, plus $3.5 billion in new capital, equals the $35 billion post-money figure. The scale of the oversubscription, the company raised more than double its original target, reflects the market impact of the July 16 launch of Kimi K3, which drove a sixfold surge in daily sales.
State and Private Capital Converge
Among the lead investors confirmed by Bloomberg was China’s National Artificial Intelligence Industry Investment Fund, an $8.8 billion state-backed vehicle established in January 2025. That same fund took a lead position in DeepSeek’s $7.4 billion debut round, a structure that drew sustained scrutiny from Western governments and analysts.
The investor roster now includes Alibaba, Tencent, HongShan (formerly Sequoia China), IDG Capital, Meituan’s venture arm Long-Z Investments, and China Mobile. The composition signals a transition: early rounds featured internet-sector strategics; the most recent rounds include China Mobile, state-linked pension assets, and government industry funds. Private money and state money are no longer separate pools.
Revenue Growth Justifies the Hype
The company’s annual recurring revenue reached $300 million in June 2026, up from $200 million in April and $100 million in March — a near-tripling in roughly four months, with API licensing accounting for more than 70% of total revenue. As EastFrontier has previously reported, Moonshot AI crossed $100 million ARR just one month after launching Kimi K2.5, the K3 launch has now tripled that figure in a similar timeframe.
At a $35 billion valuation against $300 million in ARR, the implied price-to-ARR multiple exceeds 100×, a level that prices in a revenue trajectory Moonshot’s four-month history supports in direction, but not yet in scale. The massive influx of capital, combined with the successful launch of Kimi K3, solidifies Moonshot AI’s position as a leading force in China’s generative AI landscape. As the company prepares for a highly anticipated IPO, its ability to maintain this explosive growth while managing the technical and regulatory challenges of frontier AI development, including the hallucination issues flagged by independent evaluators, will be closely watched by global markets.
The state capital dimension of the round also deserves scrutiny. The National AI Fund’s participation in both DeepSeek’s and Moonshot’s largest rounds suggests that Beijing is deliberately concentrating strategic capital in the two Chinese AI labs most likely to compete at the global frontier. This is not passive investment; it is industrial policy expressed through the balance sheet. For Western governments and investors trying to assess the competitive threat from Chinese AI, the convergence of state and private capital in Moonshot’s cap table is a signal that the company’s ambitions, and its resources, are backed by the full weight of China’s AI development strategy.
The planned Hong Kong IPO, if it proceeds at the $50 billion pre-money valuation Moonshot is currently targeting, would be one of the largest technology listings in the city’s history and a significant test of international investor appetite for Chinese AI at frontier valuations. It would also give Moonshot access to a broader pool of global capital while keeping the company listed in a jurisdiction that remains accessible to both Chinese and international investors. The outcome of that listing will be a bellwether not just for Moonshot, but for the entire cohort of Chinese AI unicorns that are now approaching IPO scale.
For now, the $3.5 billion close is a milestone that validates the Kimi K3 launch as a genuine commercial inflection point and positions Moonshot as one of the two or three Chinese AI labs with the resources to compete at the global frontier. The simultaneous fundraising triumph and hallucination controversy that defined the week of July 28 capture the essential tension of China’s AI moment: extraordinary capability gains, extraordinary capital formation, and extraordinary questions about reliability and governance that remain unresolved. Whether Moonshot can resolve those tensions, delivering both the benchmark performance that attracts capital and the factual reliability that retains enterprise customers, will determine whether its current valuation proves prescient or premature.
The next six months, which will include the Hong Kong IPO process and the expected release of Kimi K4, will be the most consequential in the company’s short history, and among the most consequential for the broader question of whether China’s AI labs can sustain frontier competition not just in capability benchmarks but in the commercial and reliability dimensions that enterprise adoption ultimately demands.